Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Major bleeding complications in a specialized anticoagulation service.

John Fanikos1, Nicole Grasso-Correnti, Ravi Shah

  • 1Department of Pharmacy, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, USA.

The American Journal of Cardiology
|August 16, 2005
PubMed
Summary

Major bleeding complications from warfarin anticoagulation therapy were studied in over 2,400 patients. The study found a low incidence of nonfatal bleeding events, primarily intracranial hemorrhages, with significant hospitalization costs.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Clinical and patient-reported outcomes after drug-coated balloon angioplasty for femoropopliteal peripheral artery disease.

VASA. Zeitschrift fur Gefasskrankheiten·2026
Same author

Ultrasound-Facilitated, Catheter-Directed Fibrinolysis for Acute Pulmonary Embolism.

The New England journal of medicine·2026
Same author

Post-pulmonary embolism cardiac impairment and chronic thromboembolic pulmonary hypertension after ultrasound-assisted catheter-directed thrombolysis for acute pulmonary embolism.

Clinical research in cardiology : official journal of the German Cardiac Society·2026
Same author

Sirolimus-Coated Balloon Angioplasty for Infrainguinal Artery Disease.

The New England journal of medicine·2026
Same author

Extended Low-Dose Apixaban and Superficial Vein Thrombosis: Post Hoc Analysis of the HI-PRO Randomized Clinical Trial.

JAMA cardiology·2026
Same author

Endovascular treatment of acute upper extremity deep vein thrombosis in Paget-Schroetter syndrome: A longitudinal analysis of three endovascular techniques.

Journal of vascular surgery. Venous and lymphatic disorders·2026

Area of Science:

  • Cardiology
  • Pharmacology
  • Public Health

Background:

  • Warfarin is a widely used anticoagulant for conditions like atrial fibrillation and venous thromboembolic disease.
  • Understanding the risk and characteristics of major bleeding complications is crucial for patient safety and effective anticoagulation management.
  • Previous studies have established warfarin's efficacy but require updated data on bleeding profiles in diverse patient populations.

Purpose of the Study:

  • To investigate the incidence and characteristics of major bleeding complications in patients receiving warfarin therapy.
  • To determine the types of major bleeding events, associated patient factors, and healthcare resource utilization.
  • To provide current data on warfarin-related bleeding risks for clinical decision-making.

Main Methods:

Related Experiment Videos

  • Retrospective analysis of 2,460 patients with 3,684 patient-years of warfarin exposure between 2000 and 2003.
  • Inclusion criteria focused on patients with documented warfarin use and subsequent major bleeding events.
  • Data collection included patient demographics, indications for anticoagulation, bleeding event details, and hospitalization costs.

Main Results:

  • A total of 12 nonfatal major bleeding complications occurred in 11 patients; no fatal bleeds were reported.
  • The incidence of major bleeding complications was 0.12% per year (0.32 bleeds per 100 patient-years).
  • Intracranial hemorrhages accounted for 42% of the bleeding events, with an average hospitalization cost of $15,988 and a mean stay of 6.0 days.

Conclusions:

  • Warfarin anticoagulation in this cohort demonstrated a low incidence of major bleeding complications.
  • Intracranial hemorrhage was the most frequent type of major bleed, highlighting a critical area for monitoring and prevention.
  • The findings underscore the importance of vigilant patient monitoring to mitigate bleeding risks and associated healthcare costs.